🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

First Affiliated Hospital of Kunming Medical University clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with First Affiliated Hospital of Kunming Medical University as lead sponsor. Synced 26 Sep 2026
5Current trials
3Recruiting now
2Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

First Affiliated Hospital of Kunming Medical University is the lead sponsor of 5 current clinical trials in our China register. 3 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Esketamine and Fecal Microbiota Transplantation. The most-studied condition is Postoperative Neurocognitive Dysfunction.

ClinicalTrials.gov trials by status

  • Recruiting360%
  • Not yet open120%
  • By invitation120%

Trials by phase

  • Observational240%
  • Phase 1/2120%
  • Not applicable120%
  • Phase 2120%
01

Clinical trials sponsored by First Affiliated Hospital of Kunming Medical University

5 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Perioperative IL-33 is Associated with the Early Stage of Postoperative Neurocognitive Dysfunction After Major Abdominal Surgery
NCT06704451 · ClinicalTrials.gov ↗ · Postoperative Neurocognitive Dysfunction, Cognitive Dysfunction, Postoperative Complications
Observational Recruiting 2014-08 China
Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
NCT06775821 · ClinicalTrials.gov ↗ · Abdominal Aortic Aneurysm, Primary Lung Cancer, Prevalence
Observational Recruiting 2022-10 China
Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors
NCT07814456 · ClinicalTrials.gov ↗ · Ulcerative Colitis (UC), Inflammatory Bowel Disease
Phase 2 Recruiting 2026-02 China
Effect of Liposome Bupivacaine Serratus Plane Block on Postoperative Hyperalgesia and Chronic Post-surgical Pain in Patients Undergoing Radical Mastectomy
NCT07289178 · ClinicalTrials.gov ↗ · Serratus Plane Block, Postoperative Hyperalgesia, Chronic Post-surgical Pain
Phase 1/2 Not yet open 2026-01 China
The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery
NCT07125573 · ClinicalTrials.gov ↗ · Esketamine Plus Dexmedetomidine Affect Postoperative Quality, Thoracoscopy, Lung Neoplasms
Not applicable By invitation 2025-05 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in First Affiliated Hospital of Kunming Medical University trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in First Affiliated Hospital of Kunming Medical University trials

16 conditions
Postoperative Neurocognitive Dysfunction1Cognitive Dysfunction1Postoperative Complications1Neuropsychological Tests1Abdominal Aortic Aneurysm1Primary Lung Cancer1Prevalence1Serratus Plane Block1Postoperative Hyperalgesia1Chronic Post-surgical Pain1Liposomal Bupivacaine1Esketamine Plus Dexmedetomidine Affect Postoperative Quality1Thoracoscopy1Lung Neoplasms1Ulcerative Colitis (UC)1Inflammatory Bowel Disease1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China53

A trial with sites in more than one country appears in each of those registers.

05

Questions about First Affiliated Hospital of Kunming Medical University trials

How many clinical trials does First Affiliated Hospital of Kunming Medical University sponsor?

First Affiliated Hospital of Kunming Medical University is the lead sponsor of 5 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are First Affiliated Hospital of Kunming Medical University trials recruiting?

Yes. 3 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is First Affiliated Hospital of Kunming Medical University testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Esketamine (1) and Fecal Microbiota Transplantation (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.